AIHTA - Publications - Search - Items where Subject is "WP 440-468 Uterine diseases"
Number of items at this level: 11.

Fischer, S. and Kisser, A. (2015): Robot-assisted surgery: A systematic review of effectiveness and safety for elected indications and accumulating costs. HTA-Projektbericht 84.

Fischer, S. and Warmuth, M. (2012): Radiofrequency Ablation for the Treatment of Tumours of the Urogenital Tract (Renal Cell Carcinoma, Prostate Cancer and Uterine Leiomyoma). Decision Support Document 59.

Fischer, S. and Zechmeister-Koss, I (2012): Day Surgery. HTA- Projektbericht 64.

Grössmann, N. (2020): Niraparib (Zejula®) in patients with newly diagnosed advanced ovarian cancer. Oncology Fact Sheet Nr. 22.

Grössmann, N. (2020): Olaparib (Lynparza®) plus bevacizumab as first-line maintenance treatment in patients with ovarian cancer. Oncology Fact Sheet Nr. 24.

Hepperger, C. and Nachtnebel, A. (2014): Bevacizumab (Avastin®) for platinum-resistant recurrent, epithelial ovarian, fallopian tube or primary peritoneal cancer. DSD: Horizon Scanning in Oncology 48.

Hintringer, K. (2010): Trabectedin (Yondelis ®) for second-line recurrent platinum-sensitive ovarian cancer. DSD: Horizon Scanning in Oncology 07.

Kisser, A. and Kirisits, A. (2014): Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of peritoneal carcinomatosis . Decision Support Document 74.

Lambert, R. and Strohmaier, C. (2020): Intrauterine ultrasound-guided transcervical radiofrequency ablation. Decision Support Document 120.

Wild, C. (2004): [Endometrial ablation techniques in the treatment of uterine bleeding]. HTA-Newsletter 32: p. 2.

Wild, C. (2004): [Methods of hysterectomy]. HTA-Newsletter 30: p. 2.

This list was generated on Fri Oct 30 09:00:24 2020 CET.